TScan Therapeutics Files 8-K Report

Ticker: TCRX · Form: 8-K · Filed: Apr 16, 2024 · CIK: 1783328

Tscan Therapeutics, Inc. 8-K Filing Summary
FieldDetail
CompanyTscan Therapeutics, Inc. (TCRX)
Form Type8-K
Filed DateApr 16, 2024
Risk Levellow
Pages5
Reading Time6 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, 8-K

TL;DR

TScan Therapeutics filed an 8-K, mostly boilerplate for now.

AI Summary

On April 16, 2024, TScan Therapeutics, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements, with no specific material events or financial figures detailed in the provided excerpt. The company is incorporated in Delaware and headquartered in Waltham, Massachusetts.

Why It Matters

This 8-K filing indicates that TScan Therapeutics, Inc. is providing updates or disclosures to the SEC, which could be relevant for investors monitoring the company's regulatory compliance and operational status.

Risk Assessment

Risk Level: low — The provided excerpt of the 8-K filing does not contain specific material events or financial data that would indicate a high or medium risk.

Key Players & Entities

  • TScan Therapeutics, Inc. (company) — Registrant
  • Delaware (jurisdiction) — State of incorporation
  • Waltham, Massachusetts (location) — Principal executive offices

FAQ

What is the primary purpose of this 8-K filing for TScan Therapeutics, Inc.?

The filing is a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, indicating disclosures related to 'Regulation FD Disclosure', 'Other Events', and 'Financial Statements and Exhibits'.

When was this 8-K report filed?

The report was filed on April 16, 2024.

What is TScan Therapeutics, Inc.'s state of incorporation?

TScan Therapeutics, Inc. is incorporated in Delaware.

Where are TScan Therapeutics, Inc.'s principal executive offices located?

The principal executive offices are located at 830 Winter Street, Waltham, Massachusetts, 02451.

Does the filing excerpt provide specific financial details or material events?

No, the provided excerpt of the 8-K filing does not detail specific financial figures or material events, focusing instead on the form type and company identification.

Filing Stats: 1,404 words · 6 min read · ~5 pages · Grade level 12.7 · Accepted 2024-04-16 16:16:09

Key Financial Figures

  • $0.0001 — which registered Voting Common Stock, $0.0001 par value per share TCRX The Nasdaq

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 99.1 Press release, dated April 16, 2024 99.2 Company Presentation 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

Forward-Looking Statements

Forward-Looking Statements This Current Report on Form 8-K contains forward-looking statements that are based on the Company's beliefs and assumptions and on information currently available to the Company on the date of this Current Report. These forward-looking statements involve substantial risks and uncertainties. Any statements in this Current Report on Form 8-K other than statements of historical fact, including statements about the Company's future expectations, plans and prospects, constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Forward-looking statements include any statements about the Company's strategy, operations and future expectations and plans and prospects for the Company, and any other statements containing the words "anticipate," "believe," "estimate," "expect," "intend", "goal," "may", "might," "plan," "predict," "project," "seek," "target," "potential," "will," "would," "could," "should," "continue," and similar expressions. Such forward-looking statements involve substantial risks and uncertainties that could cause the Company's financial and operating results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements, including the factors discussed in the "Risk Factors" section contained in the quarterly and annual reports that the Company files with the Securities and Exchange Commission. Any forward-looking statements represent the Company's views only as of the date of this Current Report on Form 8-K. The Company anticipates that subsequent events and developments may cause its views to change. While the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so except as required by law even if new information becomes available in the future. SIGNATURE Pursuant to the requirements of the Securit

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.